iBio (IBIO) Accumulated Expenses (2011 - 2026)

iBio (IBIO) has 16 years of Accumulated Expenses data on file, last reported at $1.8 million in Q1 2026.

• On a quarterly basis, Accumulated Expenses rose 34.87% year-over-year to $1.8 million in Q1 2026; TTM through Mar 2026 was $1.8 million, a 34.87% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 33.68% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $1.8 million, up from $1.6 million in the prior quarter.
• Over the last five years, Accumulated Expenses for IBIO reached as high as $5.0 million in Q4 2022 and fell as low as $183000.0 in Q2 2023.
• Historically, Accumulated Expenses has averaged $2.4 million across 5 years, with a median of $2.0 million in 2024.
• Across the five-year window, Accumulated Expenses tumbled 94.03% in 2023 and jumped 1008.2% in 2024, its largest moves.
• Year by year, Accumulated Expenses stood at $5.0 million in 2022, then fell by 24.88% to $3.8 million in 2023, then tumbled by 51.16% to $1.8 million in 2024, then fell by 13.95% to $1.6 million in 2025, then advanced by 13.17% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Accumulated Expenses figures were $1.8 million in Q1 2026, $1.6 million in Q4 2025, and $850000.0 in Q3 2025.